Literature DB >> 26848118

Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.

Ian G Barr1, Dhanasekaran Vijaykrishna, Sheena G Sullivan.   

Abstract

Influenza B viruses make up an important part of the burden from seasonal influenza globally. The 2015 season in Australia saw an unusual predominance of influenza B with a distinctive switch during the season from B/Yamagata/16/88 lineage viruses to B/Victoria/2/87 lineage viruses. We also noted significant differences in the age groups infected by the different B lineages, with B/Victoria infecting a younger population than B/Yamagata, that could not be explained by potential prior exposure.

Keywords:  epidemiology; influenza; laboratory; laboratory surveillance; molecular methods; public health policy; statistics; surveillance; vaccines and immunisation; viral infections

Mesh：

Year:  2016        PMID： 26848118     DOI： 10.2807/1560-7917.ES.2016.21.4.30118

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  23 in total

1.  Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Authors:  Karen L Laurie; William Horman; Louise A Carolan; Kok Fei Chan; Daniel Layton; Andrew Bean; Dhanasekaran Vijaykrishna; Patrick C Reading; James M McCaw; Ian G Barr
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

2.  Population-Based Pediatric Hospitalization Burden of Lineage-Specific Influenza B in Hong Kong, 2004-2014.

Authors:  Benjamin J Cowling; Peng Wu; Janice Y C Lo; Kwok-Hung Chan; Eunice L Y Chan; Vicky J Fang; Lok-Yee So; J S Malik Peiris; Susan S Chiu
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

Review 3.  Reverse genetics for influenza B viruses and recent advances in vaccine development.

Authors:  Stivalis Cardenas-Garcia; C Joaquin Caceres; Daniela Rajao; Daniel R Perez
Journal:  Curr Opin Virol       Date:  2020-11-27       Impact factor: 7.090

4.  Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.

Authors:  Johanna M McAnerney; Sibongile Walaza; Stefano Tempia; Lucille Blumberg; Florette K Treurnicht; Shabir A Madhi; Ziyaad Valley-Omar; Cheryl Cohen
Journal:  Influenza Other Respir Viruses       Date:  2016-12-20       Impact factor: 4.380

5.  Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.

Authors:  Mpho Seleka; Florette K Treurnicht; Stefano Tempia; Orienka Hellferscee; Senzo Mtshali; Adam L Cohen; Amelia Buys; Johanna M McAnerney; Terry G Besselaar; Marthi Pretorius; Anne von Gottberg; Sibongile Walaza; Cheryl Cohen; Shabir A Madhi; Marietjie Venter
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.

Authors:  Joan Puig-Barberà; Elena Burtseva; Hongjie Yu; Benjamin J Cowling; Selim Badur; Jan Kyncl; Anna Sominina
Journal:  BMC Public Health       Date:  2016-08-22       Impact factor: 3.295

Review 7.  Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.

Authors:  Lance Jennings; Qiu Sue Huang; Ian Barr; Ping-Ing Lee; Woo Joo Kim; Philippe Buchy; Melvin Sanicas; Bruce A Mungall; Jing Chen
Journal:  Influenza Other Respir Viruses       Date:  2018-03-07       Impact factor: 4.380

8.  Epidemiology of seasonal influenza infection in pregnant women and its impact on birth outcomes.

Authors:  A K Regan; H C Moore; S G Sullivan; N DE Klerk; P V Effler
Journal:  Epidemiol Infect       Date:  2017-09-11       Impact factor: 4.434

9.  Epidemiology of influenza B in Australia: 2001-2014 influenza seasons.

Authors:  Aye M Moa; David J Muscatello; Robin M Turner; Chandini R MacIntyre
Journal:  Influenza Other Respir Viruses       Date:  2016-10-14       Impact factor: 4.380

10.  Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.

Authors:  Sanie Sesay; Jerzy Brzostek; Ingo Meyer; Yves Donazzolo; Geert Leroux-Roels; Régine Rouzier; Béatrice Astruc; Henryk Szymanski; Nicole Toursarkissian; Corinne Vandermeulen; Edyta Kowalska; Pierre Van Damme; Camille Salamand; Stephanie Pepin
Journal:  Hum Vaccin Immunother       Date:  2017-11-27       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.